Tumor microenvironment mimicking 3D models unveil the multifaceted effects of SMAC mimetics.

Autor: Pinto C; Cancer Immunology and Immune Modulation, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Slavic-Obradovic K; Cancer Pharmacology and Disease Positioning, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Fürweger D; Cancer Immunology and Immune Modulation, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Thaler B; Cancer Immunology and Immune Modulation, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Souabni A; Cancer Immunology and Immune Modulation, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Carotta S; Cancer Cell Signaling, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Aichinger M; Cancer Pharmacology and Disease Positioning, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Reiser U; Medicinal Chemistry, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Impagnatiello MA; Global BD&L, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria., Tirapu I; Cancer Immunology and Immune Modulation, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.

Publikováno v: IScience [iScience] 2023 Mar 11; Vol. 26 (4), pp. 106381. Date of Electronic Publication: 2023 Mar 11 (Print Publication: 2023).